论文部分内容阅读
由于胎牛血清(FBS)成分复杂、价格昂贵和供应不足等问题,作者发现,低蛋白血清替代因子(LPSR-1)可支持不同哺乳动物培养细胞的生长和病毒复制,可使成本降低28%,胎牛血清用量节省75%,因而可望用于疫苗生产.
Due to the complex, expensive and under-supplied components of fetal bovine serum (FBS), the authors found that low-protein serum replacement factor (LPSR-1) can support growth and viral replication in cultured cells of different mammalian species with a cost reduction of 28% , Saving 75% fetal bovine serum, which is expected to be used for vaccine production.